This inventor holds 5 USPTO granted patents. Top assignees: Chiron Corporation, Cephalon, Inc., Other. Active years: 1997-2007.
Location History:
- Oakland, CA (US) (1997)
- Bellevue, WA (US) (2006 - 2007)
Company Filing History:
4 out of 672 
2 out of 248 
1 out of 834,411 Years Active: 1997-2007
Title: The Innovations of Carl Scandella
Introduction
Carl Scandella is a notable inventor based in Oakland, CA. He has made significant contributions to the field of biotechnology, particularly in the purification of insulin-like growth factors (IGF). With a total of 5 patents to his name, Scandella's work has had a substantial impact on medical research and applications.
Latest Patents
Among his latest patents, Scandella has developed methods for purifying authentic IGF from yeast hosts. These methods involve a refolding step and are designed to yield high amounts of properly folded IGF polypeptides from various yeast strains. This innovation is crucial for ensuring the availability of authentic IGF for research and therapeutic purposes.
Career Highlights
Throughout his career, Scandella has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Chiron Corporation and Cephalon, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking advancements in his field.
Collaborations
Scandella has collaborated with several esteemed professionals, including Nancy L. Haigwood and Cynthia A. Cowgill. These partnerships have fostered a collaborative environment that has led to innovative solutions in biotechnology.
Conclusion
Carl Scandella's contributions to the field of biotechnology, particularly through his patents and collaborations, highlight his role as a significant inventor. His work continues to influence the development of methods for purifying IGF, showcasing the importance of innovation in medical research.